XML 89 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Geneos Therapeutics, Inc. - Preferred Stock Investment (Details) - USD ($)
1 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Noncontrolling Interest [Line Items]        
Share in current and accumulated net loss of Geneos   $ (2,165,213) $ (434,387) $ (4,584,610)
Series A-2 One Preferred Stock        
Noncontrolling Interest [Line Items]        
Beginning balance   1,999,998    
Remeasurement of Geneos Series A-1 preferred stock $ 165,000 165,215    
Share in current and accumulated net loss of Geneos (2,200,000) (2,165,213)    
Ending balance $ 0 $ 0 $ 1,999,998